Khanna J M, Kalant H, Weiner J, Chau A, Shah G
Department of Pharmacology, University of Toronto, Ontario, Canada.
Pharmacol Biochem Behav. 1992 Jun;42(2):347-50. doi: 10.1016/0091-3057(92)90538-q.
Motor impairment (tilt-plane test) was used to investigate whether the noncompetitive N-methyl-D-aspartate (NMDA) antagonist ketamine prevents the development of chronic and acute tolerance to ethanol. Rats were treated with ethanol or saline in the presence and absence of ketamine (separate groups) for 10 days and tested for ethanol tolerance in the absence of ketamine on the fifth and tenth days. In other studies, the effect of ketamine on acute tolerance to ethanol was examined. Rats that received ethanol daily without ketamine showed significant tolerance to ethanol on days 5 and 10, but those receiving ethanol plus ketamine daily showed significantly less tolerance to ethanol. Thus, ketamine interfered with the development of chronic tolerance just as it had been found previously to prevent rapid tolerance. In contrast, ketamine failed to block acute tolerance to ethanol. These results would suggest that the phenomena of acute tolerance and chronic tolerance have differences not previously reported.
运动功能障碍(倾斜平面试验)被用于研究非竞争性N-甲基-D-天冬氨酸(NMDA)拮抗剂氯胺酮是否能预防对乙醇的慢性和急性耐受性的形成。在有和没有氯胺酮的情况下(分为不同组),用乙醇或生理盐水对大鼠进行为期10天的处理,并在第5天和第10天在没有氯胺酮的情况下测试大鼠对乙醇的耐受性。在其他研究中,检测了氯胺酮对乙醇急性耐受性的影响。每天接受乙醇但未接受氯胺酮的大鼠在第5天和第10天对乙醇表现出显著的耐受性,但每天接受乙醇加氯胺酮的大鼠对乙醇的耐受性明显较低。因此,氯胺酮干扰了慢性耐受性的形成,正如之前发现它能预防快速耐受性一样。相比之下,氯胺酮未能阻断对乙醇的急性耐受性。这些结果表明,急性耐受性和慢性耐受性现象存在以前未报道过的差异。